Skip to content
Advertisement

FILE - This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administration called for a government investigation into highly unusual contacts between some of her agency's drug reviewers and the maker of the controversial new Alzheimer's drug. (Biogen via AP, File)

FILE - This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administration called for a government investigation into highly unusual contacts between some of her agency's drug reviewers and the maker of the controversial new Alzheimer's drug. (Biogen via AP, File)

Featured Photo Galleries